NonprofitsNick Gilbert Neurofibromatosis Research Institute

Medical Research

Nick Gilbert Neurofibromatosis Research Institute

DETROIT, MI

Total revenue

$150K

Total expenses

$1

Net assets

$150K

Grants received

EIN

993110088

Tax year

2024

Mission

The principal purpose of the institute is to actively and continuously engage directly in the conduct of medical research, both on its own and in conjunction with one or more hospitals and universities. The institute has begun its initial efforts in scientific and medical research to accelerate the development of research findings and technologies that will lead to the creation of new medicines, new diagnostics, and other enabling products to treat patients with neurofibromatosis ("nf") and other debilitating neuronal diseases and related conditions. In the current year, the institute has established research partnerships and began construction on its operational space.

Financials

FY 2024

Revenue

Contributions & grants$150K
Program service revenue
Investment income
Other revenue
Total revenue$150K

Expenses

Grants paid
Salaries & benefits
Fundraising
Other expenses$1
Total expenses$1
Total assets$150K
Net assets$150K

People

5 listed

NameRoleCompensation

LAURA GRANNEMANN

PRESIDENT, DIRECTOR

Board

0

JEFFREY MORGANROTH

SECRETARY, DIRECTOR

Board

0

MATTHEW RIZIK

TREASURER, DIRECTOR

Board

0

DANIEL GILBERT

DIRECTOR

Board

0

JENNIFER GILBERT

DIRECTOR

Board

0

Details

EIN993110088
NTEE codeH99
Subsection03
Ruling date2025-12
NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE — Mission, Financials & Grants Received | Grantivo